Skip to content
Trial Eligibility
Menu

Evaluating Treatments for Suicidal Veterans With PTSD

NCT05974631

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

Posttraumatic Stress Disorder (PTSD) is a significant driver of suicide risk among Veterans, but there is a critical knowledge gap about how to treat PTSD among people at elevated risk for suicide. Although evidence-based treatments for PTSD reduce suicide risk, Veterans at high risk for suicidal behavior rarely receive these potentially life-saving treatments. Prior research suggests that a treatment that combines Dialectical Behavior Therapy (DBT) with the DBT Prolonged Exposure protocol (DBT PE) for PTSD improves both PTSD and suicide-related outcomes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Self-directed Violence
  • Post-traumatic Stress Disorder (PTSD)

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
VA Office of Research and Development
Last updated on ClinicalTrials.gov
July 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Minnesota · 1

  • Minneapolis VA Health Care System, Minneapolis, MN · Minneapolis, MN

North Carolina · 1

  • Durham VA Medical Center, Durham, NC · Durham, NC

Texas · 1

  • South Texas Health Care System, San Antonio, TX · San Antonio, TX

Washington · 1

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA · Seattle, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.